Akira Chikamoto Selected Research

Akira Chikamoto Research Topics

Disease

88	Neoplasms (Cancer) 12/2022 - 02/2005
51	Hepatocellular Carcinoma (Hepatoma) 09/2022 - 09/2011
25	Neoplasm Metastasis (Metastasis) 01/2021 - 02/2005
20	Pancreatic Neoplasms (Pancreatic Cancer) 03/2021 - 02/2005
10	Cholangiocarcinoma 04/2020 - 12/2013
9	Adenocarcinoma 12/2022 - 02/2005
7	Lymphatic Metastasis 01/2022 - 09/2017
7	Pancreatic Fistula (Pancreatic Fistulas) 08/2018 - 09/2007
6	Liver Diseases (Liver Disease) 12/2016 - 12/2012
6	Carcinoma (Carcinomatosis) 01/2014 - 05/2006
4	Inflammation (Inflammations) 02/2022 - 12/2017
4	Fibrosis (Cirrhosis) 01/2022 - 11/2014
4	Hemorrhage 08/2020 - 05/2012
4	Carcinogenesis 12/2017 - 07/2012
3	Disease Progression 02/2020 - 10/2013
3	Thrombosis (Thrombus) 01/2019 - 05/2015
3	Ascites 12/2017 - 10/2013
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 05/2014
2	False Aneurysm (Pseudoaneurysm) 08/2020 - 05/2017
2	Klatskin Tumor 04/2020 - 12/2016
2	Primitive Neuroectodermal Tumors (PNET) 01/2019 - 09/2017
2	Dysbiosis 12/2017 - 01/2017
2	Sarcopenia 10/2017 - 04/2016
2	Disseminated Intravascular Coagulation 08/2015 - 08/2012
2	Colonic Neoplasms (Colon Cancer) 01/2015 - 11/2012
2	Colorectal Neoplasms (Colorectal Cancer) 10/2014 - 03/2013
2	Insulinoma 12/2013 - 08/2013
2	Neoplasms, Cystic, Mucinous, and Serous 08/2013 - 07/2012
2	Cholangitis 06/2012 - 04/2005
1	Head and Neck Neoplasms (Head and Neck Cancer) 12/2022
1	Diabetes Mellitus 12/2022
1	Diaphragmatic Hernia 05/2021
1	Hepatic Infarction 08/2020
1	Liver Abscess 08/2020
1	Sepsis (Septicemia) 08/2020

Drug/Important Bio-Agent (IBA)

11	Tumor Biomarkers (Tumor Markers)IBA 03/2021 - 08/2012
7	AntigensIBA 12/2022 - 08/2010
7	CarbohydratesIBA 12/2022 - 08/2010
7	Carcinoembryonic AntigenIBA 03/2021 - 08/2010
7	Fluorouracil (Carac)FDA LinkGeneric 01/2018 - 02/2005
6	Gemcitabine FDA Link 02/2020 - 02/2005
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2015
5	AlbuminsIBA 01/2022 - 01/2018
5	Proteins (Proteins, Gene)FDA Link 11/2021 - 07/2012
5	DNA (Deoxyribonucleic Acid)IBA 06/2019 - 01/2016
5	Fetal Proteins (Fetoprotein)IBA 02/2019 - 01/2018
5	Prothrombin (Factor II)IBA 01/2019 - 09/2017
4	Cisplatin (Platino)FDA LinkGeneric 01/2019 - 05/2007
4	Sorafenib (BAY 43-9006)FDA Link 04/2018 - 11/2011
4	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2015 - 03/2013
3	BilirubinIBA 01/2022 - 03/2013
3	Histones (Histone)IBA 01/2021 - 12/2013
3	Serum AlbuminIBA 02/2020 - 10/2013
3	alpha-Fetoproteins (alpha-Fetoprotein)IBA 02/2019 - 05/2018
3	Indicators and Reagents (Reagents)IBA 08/2017 - 11/2014
3	Therapeutic UsesIBA 03/2017 - 09/2011
3	Messenger RNA (mRNA)IBA 01/2014 - 07/2012
2	Indocyanine Green (Cardio-Green)FDA LinkGeneric 11/2019 - 09/2014
2	C-Reactive ProteinIBA 05/2019 - 01/2018
2	lentil lectinIBA 02/2019 - 01/2019
2	Human Serum Albumin FDA LinkGeneric 02/2019 - 05/2014
2	acarboxyprothrombin (PIVKA)IBA 02/2019 - 05/2018
2	ProstaglandinsIBA 01/2019 - 02/2018
2	15-hydroxyprostaglandin dehydrogenaseIBA 01/2019 - 02/2018
2	Enhancer of Zeste Homolog 2 ProteinIBA 10/2018 - 12/2013
2	ParaffinIBA 04/2018 - 01/2014
2	Bile Acids and Salts (Bile Acids)IBA 12/2017 - 12/2012
2	Cadherins (E-Cadherin)IBA 09/2015 - 01/2013
2	Dacarbazine (DIC)FDA LinkGeneric 08/2015 - 08/2012
2	Hematoxylin (Haematoxylon)IBA 01/2009 - 01/2008
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2009 - 01/2008
1	Dihydrotachysterol (AT 10)IBA 12/2022
1	UbiquitinIBA 11/2021
1	MicroRNAs (MicroRNA)IBA 11/2021
1	Proteasome Endopeptidase Complex (Proteasome)IBA 11/2021
1	Ligases (Synthetase)IBA 11/2021
1	B7-H1 AntigenIBA 06/2020

Therapy/Procedure

40	Hepatectomy 09/2022 - 11/2011
26	Drug Therapy (Chemotherapy) 01/2019 - 04/2005
22	Therapeutics 04/2020 - 01/2006
18	Radiofrequency Ablation 05/2021 - 11/2011
16	Pancreatectomy 01/2022 - 02/2005
13	Pancreaticoduodenectomy 12/2022 - 05/2010
5	Lymph Node Excision (Lymph Node Dissection) 04/2019 - 01/2017
4	Adjuvant Chemotherapy 02/2020 - 03/2013
4	Pancreaticojejunostomy 01/2015 - 08/2008
3	Erythrocyte Transfusion 01/2022 - 01/2018
3	Catheters 08/2020 - 04/2005
3	Blood Transfusion (Blood Transfusions) 11/2019 - 10/2013
3	Immunotherapy 01/2019 - 01/2017
3	Chemoradiotherapy 01/2018 - 04/2016
3	Radiotherapy 08/2012 - 02/2005
3	Combination Drug Therapy (Combination Chemotherapy) 08/2012 - 02/2005
2	Stents 08/2020 - 08/2017
2	Punctures 07/2020 - 12/2012
2	Segmental Mastectomy (Lumpectomy) 04/2020 - 12/2011
2	Length of Stay 01/2019 - 05/2012
2	Laparotomy 02/2015 - 12/2011
1	Perioperative Period 02/2022
1	Operative Surgical Procedures 07/2020